TY - JOUR
T1 - Insula activity to visceral stimulation and endocrine stress responses as associated with alexithymia in patients with irritable bowel syndrome
AU - Kano, Michiko
AU - Muratsubaki, Tomohiko
AU - Yagihashi, Mao
AU - Morishita, Joe
AU - Mugikura, Shunji
AU - Dupont, Patrick
AU - Takase, Kei
AU - Kanazawa, Motoyori
AU - Van Oudenhove, Lukas
AU - Fukudo, Shin
N1 - Funding Information:
Source of Funding and Conflicts of Interest: This research was supported by Grant–in-Aid for Scientific Research from the Ministry of Education, Science (26460898 to M.K., 15H04799, pricipal investigator: S.F.), and the research grant of The AKAEDA Foundation (to M.K.). Dr. Kano, Dr. Muratsubaki, Dr. Yagihashi, Dr. Morishita, Dr. Mugikura, Dr. Dupont, Dr. Takase, Dr. Kanazawa, Dr. Van Oudenhove, and Dr. Fukudo report no biomedical financial interests or potential conflicts of interest.
Publisher Copyright:
© Lippincott Williams & Wilkins.
PY - 2020/1/1
Y1 - 2020/1/1
N2 - Objective Few studies have investigated associations between alexithymia and physiological mechanisms in psychosomatic diseases. We examined associations between alexithymia and 1) perception and brain processing of visceral stimulation and 2) the endocrine responses to corticotrophin-releasing hormone (CRH) in healthy individuals and patients with irritable bowel syndrome (IBS). Methods The study included 29 patients with IBS and 35 age- and sex-matched healthy controls (HCs). Alexithymia was measured using the 20-item Toronto Alexithymia Scale (TAS-20). Brain responses to rectal distention and its anticipation were measured by functional magnetic resonance imaging and analyzed at a voxel-level threshold of puncorrected <.001 combined with a cluster-level threshold of pFWE-corrected <.05. On a different day, plasma adrenocorticotropic hormone and cortisol responses after intravenous CRH administration were measured. Results TAS-20 scores did not differ significantly between patients with IBS and HCs (p =.18). TAS-20 scores correlated positively with the individual rectal discomfort thresholds (βrobust = 0.49, p =.03) and negatively with the rating of fear before rectal distention (βrobust = -1.63, p =.04) in patients with IBS but not in HCs. Brain responses to rectal distention in the right insula and other brain regions were positively associated with TAS-20 scores to a greater extent in patients with IBS than in HCs. Individuals with higher TAS-20 scores (both patients with IBS and HCs) demonstrated stronger adrenocorticotropic hormone responses to CRH administration (F(4,224) = 3.54, p =.008). Conclusion Higher alexithymia scores are associated with stronger physiological responses, but lower anticipatory fear ratings and higher discomfort thresholds, particularly in patients with IBS.
AB - Objective Few studies have investigated associations between alexithymia and physiological mechanisms in psychosomatic diseases. We examined associations between alexithymia and 1) perception and brain processing of visceral stimulation and 2) the endocrine responses to corticotrophin-releasing hormone (CRH) in healthy individuals and patients with irritable bowel syndrome (IBS). Methods The study included 29 patients with IBS and 35 age- and sex-matched healthy controls (HCs). Alexithymia was measured using the 20-item Toronto Alexithymia Scale (TAS-20). Brain responses to rectal distention and its anticipation were measured by functional magnetic resonance imaging and analyzed at a voxel-level threshold of puncorrected <.001 combined with a cluster-level threshold of pFWE-corrected <.05. On a different day, plasma adrenocorticotropic hormone and cortisol responses after intravenous CRH administration were measured. Results TAS-20 scores did not differ significantly between patients with IBS and HCs (p =.18). TAS-20 scores correlated positively with the individual rectal discomfort thresholds (βrobust = 0.49, p =.03) and negatively with the rating of fear before rectal distention (βrobust = -1.63, p =.04) in patients with IBS but not in HCs. Brain responses to rectal distention in the right insula and other brain regions were positively associated with TAS-20 scores to a greater extent in patients with IBS than in HCs. Individuals with higher TAS-20 scores (both patients with IBS and HCs) demonstrated stronger adrenocorticotropic hormone responses to CRH administration (F(4,224) = 3.54, p =.008). Conclusion Higher alexithymia scores are associated with stronger physiological responses, but lower anticipatory fear ratings and higher discomfort thresholds, particularly in patients with IBS.
KW - corticotrophin-releasing hormone
KW - emotional regulation
KW - fMRI
KW - interoception
KW - psychosomatic diseases
KW - Toronto Alexithymia Scale
UR - http://www.scopus.com/inward/record.url?scp=85077296075&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85077296075&partnerID=8YFLogxK
U2 - 10.1097/PSY.0000000000000729
DO - 10.1097/PSY.0000000000000729
M3 - Article
C2 - 31609924
AN - SCOPUS:85077296075
SN - 0033-3174
VL - 82
SP - 29
EP - 38
JO - Psychosomatic Medicine
JF - Psychosomatic Medicine
IS - 1
ER -